Related Experiment Video
Updated: Aug 8, 2026
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Expression of the p53 protein and clinical and pathologic correlation in adenocarcinoma of the rectum
Márcia Teresinha Jurach1, Luise Meurer, Luis Fernando Moreira
1Department of Surgery, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.
Background:
p53 is a tumor suppressor gene that has been implicated in the pathogenesis of a wide range of tumors, including colorectal cancer.
Aim:
To evaluate the prognostic significance of p53 protein expression, and to correlate with clinical and pathologic variables as well as survival.
Patients And Methods:
Immunohistochemical staining for p53 protein was performed in a series of 83 patients with rectal cancer with a follow-up of at least 5 years.
Results:
Expression of nuclear protein was positive in 36 (43.4%) of the tumors. We found association between positive p53 and death, local recurrence, distant metastasis and overall recurrence and we also found association between p53 and death, local recurrence, metastasis and overall recurrence when analysis was adjusted to Astler-Coller stage and grade of differentiation.
Conclusion:
p53 immunoexpression has shown to be an independent prognostic factor in these series.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:23Negative Regulator Molecules